Total Payments
$6,212
2024 Payments
$481.12
Companies
38
Transactions
456
Medicare Patients
1,607
Medicare Billing
$125,468
Payment Breakdown by Category
Food & Beverage$6,212 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,212 | 456 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,462 | 123 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $771.05 | 39 | $0 (2023) |
| PFIZER INC. | $458.17 | 50 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $440.57 | 26 | $0 (2024) |
| ABBVIE INC. | $390.53 | 35 | $0 (2024) |
| Novo Nordisk Inc | $341.80 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $303.07 | 17 | $0 (2023) |
| Shire North American Group Inc | $246.23 | 22 | $0 (2019) |
| Amgen Inc. | $219.15 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $156.00 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $481.12 | 30 | ABBVIE INC. ($151.37) |
| 2023 | $676.45 | 41 | ABBVIE INC. ($213.93) |
| 2022 | $233.54 | 14 | Otsuka America Pharmaceutical, Inc. ($80.91) |
| 2021 | $489.18 | 32 | Janssen Pharmaceuticals, Inc ($237.08) |
| 2020 | $941.25 | 54 | AstraZeneca Pharmaceuticals LP ($282.29) |
| 2019 | $1,036 | 97 | Janssen Pharmaceuticals, Inc ($300.72) |
| 2018 | $1,191 | 106 | Janssen Pharmaceuticals, Inc ($291.85) |
| 2017 | $1,164 | 82 | Janssen Pharmaceuticals, Inc ($366.06) |
All Payment Transactions
456 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Bone Health | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: Cardiovascular | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: PSYCHIATRY | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Gastroenterology | ||||||
| 05/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PAIN | ||||||
| 04/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $75.49 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: PSYCHIATRY | ||||||
| 03/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 115 | 199 | $32,571 | $13,161 |
| 2022 | 9 | 428 | 664 | $99,522 | $35,154 |
| 2021 | 8 | 454 | 717 | $101,621 | $38,403 |
| 2020 | 8 | 610 | 909 | $104,302 | $38,750 |
Total Patients
1,607
Total Services
2,489
Medicare Billing
$125,468
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 128 | $17,792 | $7,120 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 37 | $7,585 | $2,997 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $4,104 | $2,269 | 55.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,090 | $775.70 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 321 | $54,136 | $16,591 | 30.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 75 | 75 | $17,100 | $9,195 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 63 | $15,624 | $4,279 | 27.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 31 | 31 | $4,110 | $2,166 | 52.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,356 | $929.42 | 68.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 41 | 66 | $3,762 | $633.74 | 16.8% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 14 | 14 | $686.00 | $506.24 | 73.8% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 12 | 12 | $540.00 | $436.51 | 80.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 48 | $2,208 | $416.04 | 18.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 177 | 383 | $60,222 | $19,848 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 75 | 75 | $17,100 | $9,375 | 54.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 48 | $11,134 | $3,550 | 31.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 44 | 44 | $4,840 | $2,923 | 60.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 43 | 91 | $5,187 | $883.61 | 17.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 47 | 47 | $1,833 | $744.05 | 40.6% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 15 | 15 | $675.00 | $558.15 | 82.7% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 14 | 14 | $630.00 | $520.94 | 82.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 225 | 464 | $57,072 | $20,110 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 52 | 52 | $11,674 | $5,699 | 48.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 67 | $11,674 | $3,669 | 31.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 54 | 54 | $4,758 | $3,294 | 69.2% |
About Dr. Jon Hall, MD
Dr. Jon Hall, MD is a Family Medicine healthcare provider based in Newburgh, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184723975.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Hall, MD has received a total of $6,212 in payments from pharmaceutical and medical device companies, with $481.12 received in 2024. These payments were reported across 456 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,212).
As a Medicare-enrolled provider, Hall has provided services to 1,607 Medicare beneficiaries, totaling 2,489 services with total Medicare billing of $125,468. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Newburgh, IN
- Active Since 09/21/2006
- Last Updated 03/12/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1184723975
Products in Payments
- XARELTO (Drug) $1,010
- INVOKANA (Drug) $433.89
- REXULTI (Drug) $423.04
- VYVANSE (Drug) $288.85
- FARXIGA (Drug) $259.84
- VRAYLAR (Drug) $238.64
- Ozempic (Drug) $191.25
- SYMBICORT (Drug) $185.40
- BREZTRI AEROSPHERE (Drug) $168.06
- CHANTIX (Drug) $146.96
- LYRICA (Drug) $146.77
- CAMZYOS (Drug) $143.41
- TRELEGY ELLIPTA (Drug) $112.60
- ENTRESTO (Drug) $105.45
- JARDIANCE (Drug) $100.63
- QULIPTA (Drug) $96.09
- JANUVIA (Drug) $95.35
- BREZTRI (Drug) $86.29
- Repatha (Biological) $84.34
- BEXSERO (Biological) $75.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Newburgh
Renee Galen, Md, MD
Family Medicine — Payments: $21,104
Family Medicine $21,104
Shannon Kratzer, Fnp, FNP
Family Medicine — Payments: $10,562
Family Medicine $10,562
Megan Missaggia, M.d, M.D
Family Medicine — Payments: $8,222
Family Medicine $8,222
Gary Riddle, M.d, M.D
Family Medicine — Payments: $7,372
Family Medicine $7,372
Elise Schutt, Fnp, FNP
Family Medicine — Payments: $7,199
Family Medicine $7,199
Jennifer Simoneaux, M.d, M.D
Family Medicine — Payments: $6,872
Family Medicine $6,872